HUP9802543A2 - Eljárás nem inzulinfüggő diabetes mellitusban szenvedő betegek esetében az adagolt exogén inzulin mennyiségének csökkentésére alkalmas tiazolindion-származékokat tartalmazó gyógyszerkészítmények előállítására - Google Patents
Eljárás nem inzulinfüggő diabetes mellitusban szenvedő betegek esetében az adagolt exogén inzulin mennyiségének csökkentésére alkalmas tiazolindion-származékokat tartalmazó gyógyszerkészítmények előállításáraInfo
- Publication number
- HUP9802543A2 HUP9802543A2 HU9802543A HUP9802543A HUP9802543A2 HU P9802543 A2 HUP9802543 A2 HU P9802543A2 HU 9802543 A HU9802543 A HU 9802543A HU P9802543 A HUP9802543 A HU P9802543A HU P9802543 A2 HUP9802543 A2 HU P9802543A2
- Authority
- HU
- Hungary
- Prior art keywords
- acyl group
- amount
- reducing
- diabetes mellitus
- dependent diabetes
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 4
- 102000004877 Insulin Human genes 0.000 title abstract 2
- 108090001061 Insulin Proteins 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 229940125396 insulin Drugs 0.000 title abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title abstract 2
- PZWGPRQVKJVQSE-UHFFFAOYSA-N thiadiazolidine-4,5-dione Chemical class O=C1NNSC1=O PZWGPRQVKJVQSE-UHFFFAOYSA-N 0.000 title 1
- 125000002252 acyl group Chemical group 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 239000000843 powder Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002723 alicyclic group Chemical group 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000005530 alkylenedioxy group Chemical group 0.000 abstract 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000002466 imines Chemical group 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány tárgya eljárás gyógyszer előállítására nem inzűlinfüggődiabetes mellitűsban szenvedő betegek esetében az adagőlt exőgéninzűlin mennyiségének csökkentésére, amely (I) általánős képletűvegyület vagy (II) (III), (IV), (V), (VI), (VII), (VIII), (IX)általánős képletű vegyületek egyikének gyógyszerészetileg elfőgadhatósója hatásős mennyiségét tartalmazza, ahől az (I) általánős képletbenR1 és R2 jelentése hidrőgénatőm vagy alkilcsőpőrt, R3 jelentésehidrőgénatőm, alifás acilcsőpőrt, valamely aliciklűsős acilcsőpőrt,arőmás acilcsőpőrt, heterőciklűsős acilcsőpőrt, aralifatikűsacilcsőpőrt, (1-6 szénatőmős alkőxi)-karbőnil-csőpőrt vagy aralkil-őxi-karbőnil-csőpőrt; R4 és R5 jelentése hidrőgénatőm, alkilcsőpőrtvagy alkőxicsőpőrt, vagy R4 és R5 jelentése együttesen alkilén-diőxi-csőpőrt; n jelentése 1, 2 vagy 3; W jelentése -CH2-, karbőnilcsőpőrtvagy CH-OR6 általánős képletű csőpőrt (ahől R6 jelentése bármely R3csőpőrt jelentésére megadőtt csőpőrt, és lehet azőnős vagy eltérő azR3 csőpőrttól); és Y és Z jelentése azőnős vagy eltérő, és mindegyikjelentése lehet őxigénatőm vagy iminőcsőpőrt (=NH). ŕ
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US209895P | 1995-08-10 | 1995-08-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP9802543A2 true HUP9802543A2 (hu) | 1999-07-28 |
Family
ID=21699238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9802543A HUP9802543A2 (hu) | 1995-08-10 | 1996-07-29 | Eljárás nem inzulinfüggő diabetes mellitusban szenvedő betegek esetében az adagolt exogén inzulin mennyiségének csökkentésére alkalmas tiazolindion-származékokat tartalmazó gyógyszerkészítmények előállítására |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0851757A2 (hu) |
| JP (1) | JPH11510508A (hu) |
| KR (1) | KR19990036290A (hu) |
| CN (1) | CN1192683A (hu) |
| AU (1) | AU724989B2 (hu) |
| BG (1) | BG102235A (hu) |
| CA (1) | CA2221241A1 (hu) |
| CZ (1) | CZ32998A3 (hu) |
| EA (1) | EA199800177A1 (hu) |
| HU (1) | HUP9802543A2 (hu) |
| IL (1) | IL122191A0 (hu) |
| NO (1) | NO980556L (hu) |
| NZ (1) | NZ313874A (hu) |
| SK (1) | SK16498A3 (hu) |
| WO (1) | WO1997005875A2 (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9711683D0 (en) * | 1997-06-05 | 1997-08-06 | Smithkline Beecham Plc | Composition |
| GB9712866D0 (en) * | 1997-06-18 | 1997-08-20 | Smithkline Beecham Plc | Novel method of treatment |
| GB2335597A (en) * | 1998-03-27 | 1999-09-29 | Glaxo Group Ltd | Stereoisomers of Troglitazone in the Treatment of Diabetes |
| FR2838968A1 (fr) * | 2002-04-30 | 2003-10-31 | Lipha | Association d'insuline et d'un derive de thiazolidinedione et son utilisation pour traiter le diabete |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
| US4873255A (en) * | 1987-02-04 | 1989-10-10 | Sankyo Company Limited | Thiazolidinone derivatives, their preparation and their use |
| US5457109A (en) * | 1993-09-15 | 1995-10-10 | Warner-Lambert Company | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| TW438587B (en) | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
-
1996
- 1996-07-29 SK SK164-98A patent/SK16498A3/sk unknown
- 1996-07-29 CA CA002221241A patent/CA2221241A1/en not_active Abandoned
- 1996-07-29 CN CN96196191A patent/CN1192683A/zh active Pending
- 1996-07-29 EP EP96926171A patent/EP0851757A2/en not_active Withdrawn
- 1996-07-29 CZ CZ98329A patent/CZ32998A3/cs unknown
- 1996-07-29 WO PCT/US1996/012430 patent/WO1997005875A2/en not_active Application Discontinuation
- 1996-07-29 EA EA199800177A patent/EA199800177A1/ru unknown
- 1996-07-29 JP JP9508479A patent/JPH11510508A/ja not_active Ceased
- 1996-07-29 NZ NZ313874A patent/NZ313874A/xx unknown
- 1996-07-29 IL IL12219196A patent/IL122191A0/xx unknown
- 1996-07-29 KR KR1019980700958A patent/KR19990036290A/ko not_active Application Discontinuation
- 1996-07-29 AU AU66411/96A patent/AU724989B2/en not_active Withdrawn - After Issue
- 1996-07-29 HU HU9802543A patent/HUP9802543A2/hu unknown
-
1998
- 1998-02-05 BG BG102235A patent/BG102235A/xx unknown
- 1998-02-09 NO NO980556A patent/NO980556L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1192683A (zh) | 1998-09-09 |
| EA199800177A1 (ru) | 1998-10-29 |
| WO1997005875A2 (en) | 1997-02-20 |
| NO980556D0 (no) | 1998-02-09 |
| NO980556L (no) | 1998-02-09 |
| CA2221241A1 (en) | 1997-02-20 |
| BG102235A (en) | 1998-09-30 |
| CZ32998A3 (cs) | 1998-10-14 |
| IL122191A0 (en) | 1998-04-05 |
| EP0851757A2 (en) | 1998-07-08 |
| AU6641196A (en) | 1997-03-05 |
| JPH11510508A (ja) | 1999-09-14 |
| SK16498A3 (en) | 1999-03-12 |
| KR19990036290A (ko) | 1999-05-25 |
| AU724989B2 (en) | 2000-10-05 |
| WO1997005875A3 (en) | 1997-03-27 |
| NZ313874A (en) | 2000-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0202017A2 (hu) | Új vegyületek | |
| ATE33838T1 (de) | Thiazolidinderivate, ihre herstellung und diese enthaltende zusammensetzungen. | |
| HUP0001285A2 (hu) | Proteáz inhibitor hatású pirrolidinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| TW341565B (en) | Indole derivatives processes and intermediates for their preparation and pharmaceutical compositions containing them | |
| HUP9802694A1 (hu) | Benzamidszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| PL335696A1 (en) | Substituted 4-arylmethylene-2-imino-2,3-dihydrothiasoles and their derivatives as well as their pharmaceutical application | |
| DE69939532D1 (de) | Gamma-aminobuttersäurederivate enthaltende, feste arzneimittel und verfahren zu ihrer herstellung | |
| CA2316902A1 (en) | Alpha-aminoamide derivatives useful as analgesic agents | |
| CA2113726A1 (en) | Use of tetrahydrocarbazone derivatives as 5ht1 receptor agonists | |
| HUP0105108A2 (hu) | Amidvegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| NZ284654A (en) | Oxazolyl substituted 3,5-dioxo-oxadiazolidine or 2,4-dioxo-thiazolidine derivatives and medicaments | |
| HUP9802270A2 (hu) | Aril-glicin-amid-származékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkompozíciók és alkalmazásuk | |
| HU9300110D0 (en) | Method for producing aryl-cycloalkyl derivatives and medical preparatives containing them as active substance | |
| RU92016545A (ru) | Гетероциклические соединения, способ их получения и фармацевтическая композиция | |
| ES8401042A1 (es) | Un procedimiento para la preparacion de nuevos derivados de triazina. | |
| TW249804B (hu) | ||
| HUT45983A (en) | Process for production of derivatives of imidazolidinone | |
| CA2461963A1 (en) | Cyclic amine compounds | |
| HUP9802543A2 (hu) | Eljárás nem inzulinfüggő diabetes mellitusban szenvedő betegek esetében az adagolt exogén inzulin mennyiségének csökkentésére alkalmas tiazolindion-származékokat tartalmazó gyógyszerkészítmények előállítására | |
| ES8609225A1 (es) | Un procedimiento para preparar un derivado de semicarbazida | |
| CA2053477A1 (en) | Heterocyclic amine derivatives, their production and use | |
| ES8600751A1 (es) | Procedimiento de producir derivados de acido oxazolacetico. | |
| ES8606880A1 (es) | Un procedimiento para la preparacion de nuevos peptidos. | |
| KR927003537A (ko) | 4, 5-사이클로알카노-3-벤즈아제핀-7-올 유도체 및 이의 용도 | |
| GEP20002212B (en) | Clavulanic Acid and Diamino Ether Derivatives, Di-Clavulanate Salt, Method for Its Production and Pharmaceutical Composition on Its Basis |